Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer

Despite being one of the most frequently diagnosed cancers worldwide, prognosis of metastatic colorectal cancer (CRC) was poor. Development and introduction of biologic agents in treatment of patients with metastatic CRC have brought improved outcomes. Monoclonal antibodies directing epidermal growt...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Suk-young, Oh, Sang Cheul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835624/
https://www.ncbi.nlm.nih.gov/pubmed/27127793
http://dx.doi.org/10.1155/2016/7590245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835624/
https://www.ncbi.nlm.nih.gov/pubmed/27127793
http://dx.doi.org/10.1155/2016/7590245

Ejemplares similares